Close
4

Seqens Seqens

X

Company profile for Bioniz Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Bioniz Therapeutics is an emerging biopharmaceutical company leading the discovery and development of first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple cytokines to treat immuno-inflammatory diseases and cancer. Originating in research conducted at the National Institutes of Health (NIH), Bioniz is leveraging its expertise in cytokine biology to create a new class of therapeutics that ...
Bioniz Therapeutics is an emerging biopharmaceutical company leading the discovery and development of first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple cytokines to treat immuno-inflammatory diseases and cancer. Originating in research conducted at the National Institutes of Health (NIH), Bioniz is leveraging its expertise in cytokine biology to create a new class of therapeutics that will tackle the issue of cytokine redundancy. Cytokine redundancy refers to how the immune system uses multiple cytokines sharing overlapping functions to prevent immune system failures from single cytokine malfunctions.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Bioniz Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
5 Mason St, Suite 275. Irvine, CA 92618
Telephone
Telephone
+1 949 273-6000
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY